Tom Van Maerken

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan et al. · Breast Cancer Research · 2016 · 118 citations · Full text

Medicine, Oncology, Pathology +17

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Huong Meeks, Honglin Song, Kyriaki Michailidou et al. · JNCI Journal of the National Cancer Institute · 2015 · 92 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Karoline Kuchenbaecker, Susan L. Neuhausen, Mark E. Robson et al. · Breast Cancer Research · 2014 · 69 citations · Full text

Life Sciences, Genetics, Oncology +17

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

Flavia Zita Francies, Tasha Wainstein, Kim De Leeneer et al. · BMC Cancer · 2015 · 55 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

Ignacio Blanco, Karoline Kuchenbaecker, Daniel Cuadras et al. · PLoS ONE · 2015 · 39 citations · Full text

Medicine, Genetics, Molecular Genetics +17